← All indications
Tuberculosis
Any of the infectious diseases of HUMANS and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.
Subtype terms (8)
More specific conditions that are subtypes of Tuberculosis in the MeSH hierarchy.
- Latent Tuberculosis
19 drugs (13 approved, 6 experimental)
- Tuberculoma
- Tuberculosis, Avian
- Tuberculosis, Bovine
- Tuberculosis Disease
- Tuberculosis, Extrapulmonary
1 drug experimental
- Tuberculosis, Multidrug-Resistant
42 drugs (31 approved, 11 experimental)
- Tuberculosis, Pulmonary
96 drugs (61 approved, 35 experimental)
Drugs by status
Approved for this indication (25)
- aminosalicylic acid
- bacille calmette-guerin
- benzimidazole
- capreomycin
- cilastatin
- cycloserine
- ethambutol
- rifampin
- pretomanid
- pyrazinamide
- rifapentine
- streptomycin
- Tuberculin, Purified Protein Derivative
- clarithromycin
- ethionamide
- protionamide
- isoniazid
- anti-tubercle serum
- tuberculin
- phenyl aminosalicylate
- amikacin
- bedaquiline
- delamanid
- tb-ppd
- EC0.1ml
Phase 4 trials (50)
- hydrocodone
- phenylephrine
- efavirenz
- linezolid
- abacavir
- acetylcysteine
- norepinephrine
- clofazimine
- atenolol
- esmolol
- ibuprofen
- doravirine
- entecavir
- sertraline
- naltrexone
- cabotegravir
- dolutegravir
- tenofovir
- calcium
- ritonavir
- whey protein
- labetalol
- lamivudine
- nevirapine
- atazanavir
- acetaminophen
- lopinavir
- rifabutin
- sulfamethoxazole
- bupivacaine
- +20 more
Phase 3 trials (43)
- metformin
- levofloxacin
- didanosine
- vitamin d3
- urea
- doxycycline
- prednisone
- aldesleukin
- amoxicillin
- meloxicam
- naproxen
- lactose
- atorvastatin
- sutezolid
- nicotine
- lidocaine
- rifamycin
- cyclophosphamide
- emtricitabine
- terizidone
- indacaterol
- Mycobacterium vaccae
- valganciclovir
- as01
- esat6-cfp10
- immunoxel
- mtbvac
- mycobacterium w vaccine
- nyaditum resae
- v7
- +13 more
Phase 2 trials (68)
- metronidazole
- alfatide
- propofol
- sodium nitrite
- thalidomide
- aeras-402
- auranofin
- canakinumab
- candida albicans allergen
- cc-11050
- clavulanate
- dar-901
- imatinib
- gsk692342
- mycobacterium tuberculosis antigen
- indinavir
- menjugate
- mva85a
- nitazoxanide
- vitamin c
- cetrorelix
- pbtz169
- pimonidazole
- azd5847
- pneumococcal 13-valent conjugate vaccine
- pravastatin
- rph201
- acetylsalicylic acid
- everolimus
- tedizolid phosphate
- +38 more
Phase 1 trials (49)
- ringer's lactate
- allopurinol
- 68ga-dotanoc
- ag85b-esat-6
- procaine benzylpenicillin
- stavudine
- faropenem medoxomil
- ethinyl estradiol
- iohexol
- celecoxib
- sq109
- tba-354
- digoxin
- adjuvanted tuberculosis subunit vaccine
- ad5ag85a
- aeras-422
- ag85b-esat6 fusion protein h1
- ap10-602
- bcg tice
- deuterated glucose
- l-epigallocatechin
- fp85a
- mva85a-imx313
- tb/flu-01l
- bupropion
- chloroquine
- caf01
- ag85b
- esat-6
- klk
- +19 more
Other trials (28)
- mannitol
- albendazole
- paroxetine
- duloxetine
- gadoteric acid
- gemcitabine
- escitalopram
- ivermectin
- fluoxetine
- peanut
- buprenorphine
- trazodone
- ulinastatin
- dexmedetomidine
- albuterol
- cisplatin
- mirtazapine
- dihydrostreptomycin
- venlafaxine
- nortriptyline
- prilocaine
- ergocalciferol
- hepatitis-a virus (inactivated) / hepatitis-b surface antigen
- dermofungin
- thonzylamine
- selenium
- tizoxanide
- mustard flour
Organizations
Organization Involved with Phase 4 Indications (128)
- University of Groningen
- Sanofi
- Japan BCG Laboratory,Tokyo
- Duke University
- National Institute of Child Health and Human Development (NICHD)
- Medical Research Council, The Gambia
- Kilimanjaro Christian Medical College, Tanzania
- University of Cape Town
- Bandim Health Project
- Federal University of Mato Grosso do Sul
- Central Institute of Epidemiology, Moscow, Russia
- Aeras
- University of Copenhagen
- Federal University of Espirito Santo
- Wellcome Trust
- Tianjin University
- The Third People's Hospital of Zhenjiang
- National Institutes of Health (NIH)
- Zhejiang University
- ViiV Healthcare
- All India Institute of Medical Sciences
- GlaxoSmithKline
- City of Rio De Janeiro Municipal Health Secretariat
- National Center for Research Resources (NCRR)
- Osaka University
- The Infectious Hospital of Hebi
- Texas Tech University
- March of Dimes
- AIDS Clinical Trials Group
- Oswaldo Cruz Foundation
- +98 more
Organization Involved with Phase 3 Indications (217)
- National Medical University, Ukraine
- District Ministry of Health, Timika
- British Lung Foundation
- Sisaket Hospital
- Madibeng Centre for Research
- Global Alliance for TB Drug Development
- Siddharth Nursing Home, Agra, U.P India
- IUATLD, Inc
- Bhumibol Adulyadej Hospital
- University of Malawi
- University of Limpopo
- Rockefeller Foundation
- Dartmouth University
- Novartis
- Serum Institute of India Pvt. Ltd.
- National Center for Tuberculosis Problems, Kazakhstan
- National Health and Medical Research Council, Australia
- New City Hospital and Trauma Centre, Lucknow, India
- Case Western Reserve University
- Statens Serum Institut
- Korean Institute of Tuberculosis
- PENTA Foundation
- ERT Clinical
- Westat
- Monash University
- University of Oxford
- Police General Hospital
- Republican Research and Practical Centre for Pulmonology and Tuberculosis
- Guru Tej Bahadur Hospital, Kanpur India
- Surya Chest Foundation, Lucknow India
- +187 more
Organization Involved with Phase 2 Indications (90)
- University of Ulsan
- Celgene
- Sequella, Inc.
- Kwame Nkrumah University of Science and Technology
- Ludwig Maximilians University
- HJ-CTC George, South Africa
- OCT Clinical Trials
- CMed Technologies Inc.
- Federal University of Rio de Janeiro
- The Research Institute of Tuberculosis, Japan
- Task Foundation NPC
- Karolinska Institute
- Northwestern University
- Immune Design
- Dankook University
- Hopital Aristide Le Dantec
- Cromos Pharma, LLC
- Government of Thailand
- Nearmedic Plus LLC
- Government of Russia
- New York University
- Shenzhen Geno-Immune Medical Institute
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Bonn
- Kalmar County Hospital
- Federal University of Bahia
- LegoChem Biosciences, Inc
- African Poverty Related Infection Oriented Research Initiative
- Columbia University
- PathCare
- +60 more
Organization Involved with Phase 1 Indications (35)
- National Institute for Health Research, United Kingdom
- University of Utah
- St. Stephens Clinical Research
- HIV Vaccine Trials Network
- Covance
- Celerion
- University of Rochester
- Innovative Medicines for Tuberculosis
- World Wide Clinical Trials Early Phase Services, LLC
- St. Louis University
- Shenzhen Third People's Hospital
- Research Institute of Influenza, Russia
- Paul G. Allen Family Foundation
- Korea University
- University of Alabama, Birmingham
- Emergent BioSolutions
- Desmond Tutu HIV Foundation
- Wuhan Jinyintan Hospital, Wuhan, China
- Shionogi
- MDS Pharma
- Imaxio
- German Center for Infection Research
- Jinan University
- University of Tampere
- University of Lausanne
- Nuvisan Pharma Services
- Corixa
- Hans Knöll Institute (HKI)
- United States Army
- Centre Hospitalier Universitaire Le Dantec
- +5 more
Organization Involved with Other Experimental Indications (37)
- Groupe Hospitalier Paris Saint Joseph
- Justus Liebig University Giessen
- Jawaharlal Institute of Postgraduate Medical Education and Research
- Institute of Liver and Biliary Sciences, India
- Bureau of Science and Technology of Guangxi Province, China
- University of Illinois at Chicago
- University of Gondar
- The Guangxi Zhuang Autonomous Region Longtan hospital
- Peking University
- Manresana de Micobacteriologia, SL
- National Natural Science Foundation of China
- Hoechst Marion Roussel
- Indonesian Directorate General of Higher Education
- Arogyavaram Medical Centre
- The Fourth People’s Hospital of Nanning
- Consorcio de Investigación sobre VIH/SIDA/TB
- Mclean Hospital
- Wenling No.1 People's Hospital, China
- National Research Institute of Tuberculosis and Lung Disease, Iran
- City of London, UK
- Food and Drug Administration
- Sun Yat-Sen University
- Genentech
- Provincial Government of Western Cape
- Midwest Pulmonary and Critical Care
- Government of Indonesia
- Taipei Medical University
- Yunnan Provincial Hospital of Infectious Diseases
- Shahid Beheshti University of Medical Sciences
- Dow University of Health Sciences
- +7 more